Atividade Leishmanicida do composto N-dodecil-1,2-etanodiamina

Abstract

With more than 12 million people affected worldwide, 2 million new cases occurring per year, and the rapid emergence of drug resistance and treatment failure, leishmaniasis is an infectious disease for which research on drug and vaccine development, hostpathogen, and vector-parasite interactions are current international priorities. Polyamines are important regulators of growth and differentiation in a variety of cells, including parasitic protozoa. The inhibition of parasitic biosynthesis by polyamines has been an interesting chemotherapeutic approach in the design of novel antiparasitic drugs against mainly leishmaniasis. In this work we evaluate the in vitro effect of N-dodecyl- 1,2-ethanediamine (GUT) on morphology and replication of Leishmania. A concentration of 0.31 μg/ml of this compound was highly effective against Leishmania amazonensis, Leishmania braziliensis and Leishmania chagasi and no toxicity against mammalian cell lines as well HFF, THP-1, J774.G8 or murine peritoneal cells was observed. So, there was inhibition of multiplication of the L. amazonensis, L. braziliensis and L. chagasi amastigotes into inflammatory peritoneal cells in presence of 1 μg/ml and 0.5 μg/ml of this compound. Promastigotes form of L. amazoneneis it was with intracellular disorganization by transmission electron microscope observation following 1 to 24 h of treatment with GUT. Thus, N-dodecyl-1,2-ethanediamine shown be a promising drug against Leishmania.